Ying Chen

Title: Ying Chen - Innovator in Peptide Compounds Targeting PD-1 Receptor

Introduction

Ying Chen is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of peptide compounds, particularly those targeting the PD-1 receptor. His innovative work has implications for the development of analgesic drugs.

Latest Patents

Ying Chen holds a patent for peptide compounds targeting the PD-1 receptor, which includes a compound 1, a compound 2, a compound 3, a compound 4, and a compound 5. These compounds comprise amino acid sequences identical to SEQ ID NO: 1-5, respectively. The method for preparing these peptide compounds involves a solid-phase synthesis method for coupling amino acids to a solid-phase resin, followed by cleavage, freeze-drying, and preparative purification. The compounds are capable of binding to PD-1 and demonstrate significant inhibitory effects on inflammatory pain and visceral pain when administered intrathecally. They are also simple to synthesize, easy to purify, and conducive to large-scale synthesis.

Career Highlights

Ying Chen is affiliated with Nantong University, where he continues to advance his research in peptide compounds. His work has garnered attention for its potential applications in pain management and therapeutic interventions.

Collaborations

Ying Chen has collaborated with notable colleagues, including Gang Chen and Long Zhao, contributing to the advancement of research in his field.

Conclusion

Ying Chen's innovative work in peptide compounds targeting the PD-1 receptor showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the development of new analgesic drugs.